Fenbendazole is a broad spectrum anthelmintic drug of class
benzimidazole. Fenbendazole is used to remove certain
gastrointestinal parasites from the stomach and intestines of
animals. It is effective against roundworms, hookworms, whipworms,
certain tapeworms, and parasites called strongyles and strongyloides,
respectively. Fenbendazole acts as an effective de-wormer as it
controls & destroys these worms by preventing their growth and
reproduction.
Ask
for In-depth Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/2244
Fenbendazole Market Driver
Increasing research and development activities for enhancing the
efficiency of fenbendazole in treating various diseases in animals
and humans is a major factor boosting growth of the fenbendazole
market. For instance, in August 2018, researchers from National
Centre for Human Genome Studies and Research (NCHGSR), India,
reported that fenbendazole has potential to act as an effective
anti-cancer agent. Fenbendazole can also be effective remedy in
evading drug resistance commonly encountered in cancer therapy. To
study this, researchers first treated human non-small cell lung
cancer cells with fenbendazole and found tumor cell death. Since,
developing a promising molecule into an approved drug often consume
considerable time and cost, repurposing of veterinary drugs in
treating diseases in humans can be effective and have shown promising
results and is expected to show cost reduction without need to
develop new drugs.
Furthermore, approval of new fenbendazole drugs is expected to drive
growth of the fenbendazole market. For instance, in January 2018,
Merck Animal Health received approval from U.S. Food and Drug
Administration (USFDA), for its Safe-Guard AquaSol, a fenbendazole
oral suspension used in the treatment and control of adult Ascaridia
galli in broiler chickens and Heterakis gallinarum in breeding
chickens via drinking water. Safe-Guard AquaSol is produced with an
innovative wet-milling technology, which produces a highly stable
suspension that can be conveniently administered to hens through
drinking water.
Fenbendazole
Market – Regional Analysis
On the basis of region, the global fenbendazole market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
North America is expected to hold dominant position in the global
fenbendazole market, owing to new developments in pet care and animal
health. For instance, in June 2018, Cargill Animal Nutrition, a
U.S.-based firm launched NutreBeef Safe-Guard (fenbendazole) Dewormer
Mineral (Medicated) in one easy-to-use package. NutreBeef Safe-Guard
Dewormer Mineral combines Safe-Guard from Merck Animal Health, with a
high quality, free-choice mineral formula from Cargill Animal
Nutrition. Safe-Guard goes directly into the gastrointestinal tract
of the parasite and once ingested by the parasite, it cannot be
excreted thus, accumulation of Safe-Guard in the parasite eventually
leads to parasite death.
Key players operating in the global fenbendazole market include,
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Hubei KangBaoTai
Fine Chemical Co., Ltd, Merck Sharp & Dohme Corp., Henan Purui
Pharmaceutical Co., Ltd., Leo Bio-care Private Limited, Supharma
Chem., Intervet Inc., LASA Supergenerics Limited, and Jiangsu Quality
Horizons Pharmtech Co., Ltd.
If
you have any speacial requirment, Talk to our Analyst
@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2244
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
